18 Recruiting Trials

Clinical Trials for Lupus in Ohio

18 clinical trials for Lupus are currently recruiting participants at study sites in Ohio. Study-related care is provided at no cost.

Showing 15 of 18 recruiting Lupus trials in Ohio

The BRIDGE Pain Study
N/A Cincinnati, Ohio NCT07602595
Recruiting
Recruiting
Recruiting
Recruiting
The Pediatric Lupus Nephritis Mycophenolate Mofetil (PLUMM) Study
PHASE2 San Francisco, California +4 sites NCT05538208
Recruiting
A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease
PHASE1 Beverly Hills, California +4 sites NCT06308978
Recruiting
Recruiting

Lupus clinical trials in Ohio: common questions

How many Lupus clinical trials are recruiting in Ohio?
TrialFinder currently lists 18 recruiting Lupus clinical trials with study sites in Ohio. Results are updated regularly from ClinicalTrials.gov, the official U.S. registry of clinical studies.
Where are Lupus clinical trials located in Ohio?
Study sites for the Lupus trials listed on this page include Cincinnati, Columbus. Each trial page lists every participating site with contact details, so you can find the location closest to you.
Do I need insurance to join a Lupus clinical trial in Ohio?
No. Study-related care is covered by the trial sponsor at no cost to participants, including the study treatment, required lab tests and study visits. Many Lupus trials in Ohio also compensate participants for time and travel. Health insurance is not required to search or enroll.
How do I qualify for a Lupus clinical trial in Ohio?
Each study sets its own criteria based on age, Lupus diagnosis details, prior treatments, current medications and general health. The fastest way to find out is to contact a research site directly — most will pre-screen you by phone in 10 to 15 minutes at no charge. You can also create a free TrialFinder profile to be matched automatically.

Check Your Eligibility

Create a free profile and our AI will match you to Lupus trials near you in Ohio.

Get Matched — Free
No insurance required

Lupus trials evaluate belimumab, anifrolumab, JAK inhibitors, and other biologics targeting the immune dysregulation behind systemic lupus erythematosus.

All Lupus trials →